The Center for Advancing Innovation Inc.

The Center for Advancing Innovation (CAI) has launched our 12th challenge -- the Global Health Innovation Challenge II (GHIC II) -- with a goal to advance innovations for the future of health. This challenge is made possible by continued support from the U.S. Economic Development Administration and CAI. Learn more in our press release at https://lnkd.in/gSkZEsqV, and join us in breaking through barriers in science to create jobs and improve health for all. #startups #innovation #venturecapital #impactinvesting #globalhealth #EconomicDevelopment #digitalbiology #AI #genetherapy #syntheticbiology

Dear Friends, The Maryland Department of Commerce is supporting a delegation of Maryland medical technology and digital health companies to attend The MedTech Conference organized by AdvaMed in Toronto, Canada, October 15-17, 2024. Here is a link to the 2024 MedTech Conference delegation application: https://lnkd.in/embsYdRN If selected to join the delegation, your company will receive: *One complimentary All-Access Pass to the 2024 MedTech Conference *Digital promotional opportunities through the Maryland Department of Commerce's marketing channels Additionally, three companies in the delegation will have the opportunity to present at the conference's Innovation Pavilion. To be eligible for the Innovation Pavilion, you must apply directly to the MedTech Conference at https://lnkd.in/ehhxufUS, in addition to completing this application to join the Maryland delegation. Selection does not include exhibition space or cover travel costs. By applying, you agree to: * Commit one representative to attend the conference in person * Provide a summary of your experience within 30 days following the conference Applications are due by COB July 10, 2024.

The Center for Advancing Innovation (CAI) invites **you** to our next virtual "Global Health Demo Day". At this event, private companies advancing technologies to hyper-accelerate the future of health will present to investors for funding. The Global Health Demo Day will be held from 1:30 PM to 3:30 PM Eastern on Monday, June 24th, 2024 using Zoom. Anyone with an interest in learning more about Tech-for-Good is invited. #innovation #tech #health #startups #fundraising #investing #socialimpact #impactinvesting #globalhealth #therapeutics #diagnostics #cancer #digitalbiology #AI #syntheticbiology

🌟Register today to join CAI and dozens of other trailblazers at the 2024 Wharton DC Innovation Summit on June 20th in McLean, Virginia at Valo Park - Tysons! 🌟 🔮Participate in 22 sessions full of groundbreaking ideas, technologies, and strategies from some of the world’s best leaders and innovators. 💡Engage with 200+ of the brightest innovative startups, government officials, and industry leaders focused on changing the fields of sustainability, healthcare, tech, and more. 🚀Explore new ideas, gain valuable knowledge, and connect with like-minded individuals. ✅Register now to join other visionary leaders in learning how to leverage an innovation ecosystem to maximize your results. #innovation #tech #entrepreneurship #sustainability #stemcells #ai #fintech #quantumcomputing #cybersecurity #globalhealth #fundraising #investing #WhartonDCInnovationSummit

Don't miss CAI challenge winner, Dr. Karim Budhwani of CerFlux, at the Newsweek Breakfast Briefing - The New Era of Life Sciences event on June 3rd. Biotechnology Innovation Organization #BIO2024 #SharkTankonSteroids #FreedomfromCancer #startups #innovation #VentureCapital #GlobalHealth #EconomicDevelopment #DigitalBiology #ArtificialIntelligence

😎 Will you be in San Diego for the Biotechnology Innovation Organization Convention? Do you want to meet dozens of investors, promising life sciences companies, and BIO's "Shark Tank on Steroids"? 🦈 Then don't miss the Healthcare Investor Brunch at Fogo de Chão, sponsored by our friends at The Big Idea CONNECTpreneur Community, JPMorgan Chase & Co., and First Republic, on Sunday, June 2nd. #NetworkingEvent #InvestorNetworking #HealthcareInvesting #LifeSciences #Biotech #Entrepreneurship #InvestorEvent #HealthcareInnovation #BiotechInvesting #SanDiegoEvents #HealthcareEntrepreneurs #LifeSciencesInvestors #BiotechStartups #VentureCapital #BIO2024 Opus8, Inc. https://lnkd.in/gstuhT9K

🎧 In this episode of my Dragons, Gazelles & Unicorns podcast, we are honored to spotlight Sheila Coates, the inspiring founder and president of Black Women United for Action. 🌟 Sheila is a passionate advocate for African-American women and families, tirelessly working to drive equity and uplift communities through education and public policy. 📚 Education is at the heart of Sheila's mission. She emphasizes the crucial role of imparting knowledge and wisdom to empower the next generation, ensuring they have the foundation to lead and innovate. 💼 Sheila’s extensive involvement in various boards and commissions has been pivotal in advocating for African-American representation and addressing vital public policy issues that affect our communities. 🏛️ At Mount Vernon, Sheila's initiatives focus on honoring the contributions of the enslaved and using education as a tool to celebrate historical and cultural heritage, fostering a deeper understanding and respect for the past. 💡 Above all, Sheila champions the values of compassion, empathy, and community support. She believes these are key in building stronger, more resilient communities that can face the future with confidence and hope. 👉 Tune into our podcast to hear Sheila share her powerful insights and stories of advocacy and change. Let's learn and grow together in the spirit of community and empowerment! #SheilaCoates #BWUFA #AfricanAmericanWomen #EducationMatters #PublicPolicy #HistoricalEducation #CommunityAdvocacy #Empowerment #Leadership #SocialChange #PodcastHighlights #DGUPodcast

🌟 Exciting breakthrough in cancer treatment! Reglagene, Inc. has received an exclusive orphan drug designation (ODD) from the FDA for RGN6024, an innovative therapy for glioblastoma, one of the most aggressive forms of brain cancer. 🧠🎗️ 🔬 RGN6024 stands out because it can cross the blood-brain barrier (BBB), a crucial challenge in treating brain diseases. This orally administered therapy attacks cancer cells directly by disrupting the function of tubulin, a protein essential for cell structure and movement. 🙌 This designation is a significant milestone as it brings hope to patients, offering a new potential treatment that can be taken at home, reducing the need for invasive procedures and minimizing side effects commonly associated with cancer treatments. 🎯 With the FDA’s orphan drug status, Reglagene will benefit from incentives like tax credits and marketing exclusivity, speeding up the development of RGN6024. This not only advances treatment for glioblastoma but also opens possibilities for addressing metastatic cancers in the brain from breast, lung, and melanoma. 💡 Reglagene is also exploring the potential of its tubulin-targeting agents in treating neuro-inflammatory diseases and ocular conditions like age-related macular degeneration and diabetic retinopathy. 👀 Meet Reglagene at the Biotechnology Innovation Organization convention in San Diego, and learn more about their journey in transforming cancer treatment and potentially improving outcomes for patients with some of the most challenging medical conditions. #CancerResearch #Glioblastoma #BrainCancer #InnovationInMedicine #FDAApproval #OrphanDrugDesignation #Healthcare #MedicalScience #Reglagene #FightCancer #CancerTherapy #Biotech #BIO2024 Texas Medical Center Innovation Factory https://lnkd.in/eBKNZ_vr

🌟 Hope is on the horizon! The End Brain Cancer Initiative (EBCI) is teaming up with SonALAsense, CAI challenge winner, to offer a groundbreaking clinical trial for children battling Diffuse Intrinsic Pontine Glioma (DIPG). The trial utilizes Sonodynamic Therapy (SDT), a noninvasive approach combining SONALA-001 and MR-guided focused ultrasound to target brain tumors more safely and effectively. 🧠💡 🔬 This innovative therapy utilizes the properties of Aminolevulinic Acid (ALA), which causes cancer cells to glow pink under blue light, allowing for precise targeting through photodynamic therapy (PDT). This trial represents a significant advance in pediatric cancer treatment, potentially offering a new lifeline to young patients. 🏥 Trial sites are active at the University of California San Francisco, Children’s National in Washington DC, and Nicklaus Children’s Hospital in Miami. 🌍 EBCI is committed to transforming the landscape of brain cancer treatment, ensuring every child has access to the best care and innovations. Join us in supporting their mission and spreading the word about this life-changing research. Together, we can bring hope and healing to countless families. 💪💚 #EndBrainCancer #BrainCancerAwareness #DIPG #PediatricCancer #CancerResearch #SonodynamicTherapy #InnovativeTreatment #HealthForAll #NonprofitSupport #FightCancer #ClinicalTrialsDay https://lnkd.in/gC7BBHvU